GREGORY JOHN M 4

4 · Tribute Pharmaceuticals Canada Inc. · Filed Mar 6, 2013

Form 4

Period: 2013-03-04

Director10% Owner

Transactions

Purchase
Common Shares
2013-03-04+625,000→ 625,000 total
Purchase
Common Shares
2013-03-04+1,250,000→ 6,438,794 total(indirect: Affiliate)
Purchase
Common Shares
2013-03-04+625,000→ 1,025,000 total(indirect: Kingsway Charities)
Purchase
Series A Common Stock Warrants (right to buy)
2013-03-04+312,500→ 312,500 total
Exercise: $0.50From: 2013-03-04Exp: 2015-03-04→ Common Stock (312,500 underlying)
Purchase
Series B Common Stock Warrants (right to buy)
2013-03-04+312,500→ 312,500 total
Exercise: $0.60From: 2013-03-04Exp: 2018-03-04→ Common Stock (312,500 underlying)
Purchase
Series A Common Stock Warrants (right to buy)
2013-03-04+625,000→ 625,000 total(indirect: Affiliate)
Exercise: $0.50From: 2013-03-04Exp: 2015-03-04→ Common Stock (625,000 underlying)
Purchase
Series B Common Stock Warrants (right to buy)
2013-03-04+625,000→ 625,000 total(indirect: Affiliate)
Exercise: $0.60From: 2013-03-04Exp: 2018-03-04→ Common Stock (625,000 underlying)
Purchase
Series A Common Stock Warrants (right to buy)
2013-03-04+312,500→ 312,500 total(indirect: Kingsway Charities)
Exercise: $0.50From: 2013-03-04Exp: 2015-03-04→ Common Stock (312,500 underlying)
Purchase
Series B Common Stock Warrants (right to buy)
2013-03-04+312,500→ 312,500 total(indirect: Kingsway Charities)
Exercise: $0.60From: 2013-03-04Exp: 2018-03-04→ Common Stock (312,500 underlying)

Footnotes (1)

[F1]The reported securities are included within Units purchased by the reporting person for $0.40 per Unit. Each Unit consists of one share of common stock, a Series A Warrant to purchase 1/2 a share of common stock, and a Series B Warrant to purchase 1/2 a share of common stock.

Documents

1 file